• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18464 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) [Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2011     Andalusian Health Technology Assessment Area (AETSA) [Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Appraisal of the variability and suitability of prescribing antimicrobials in primary health care in the Basque Country]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Approach to personality disorders in the mental health system of the Basque Country]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriate use of diagnostic imaging technologies in acute abdominal pain]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriate use of diagnostic imaging technologies in primary and secondary care : ultrasonography in breast pathology]
2005     Andalusian Health Technology Assessment Area (AETSA) [Appropriate use of Factor VIII for treatment of hemophilia - A consensus conference]
2000     Andalusian Health Technology Assessment Area (AETSA) [Appropriate use of Factor VIII in the treatment of haemophilia. A Literature review and opinions of an expert panel on the correct use of different preparations of Factor VIII]
2009     Andalusian Health Technology Assessment Area (AETSA) [Appropriate use of recombinant activated factor VII in nonhaemophilic patients]
2009     Andalusian Health Technology Assessment Area (AETSA) [Appropriateness criteria for vertebral arthrodesis]
2006     Canary Health Service [Appropriateness of the indication of physical therapy techniques]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies : appropriate admission explicit criteria for heart failure (HF)]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies. Development of appropriateness explicit criteria for carotid revascularization]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies. Development of explicit criteria for indication of admission in COPD exacerbation]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies. Efficacy and safety of pharmacological treatment for bipolar disorder]
2008     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies. Systematic review of the admission criteria in acute decompensated heart failure]
2015     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Apremilast - benefit assessment according to §35a Social Code Book V (dossier assessment)]
2015     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Aquapheresis – ultrafiltartion for congestive heart failure]
2015     The Swedish Council on Health Technology Assessment (SBU) [Arginine and caries prevention]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Argon plasma coagulation for gastrointestinal lesions]
2014     The Swedish Council on Health Technology Assessment (SBU) [Aromatase inhibitors for early-stage breast cancer]
2016     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Aromatase inhibitors in female breast cancer]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Arrhythmia ablation by EnSite NavX electroanatomical mapping]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Arterial stiffness measurement for cardiovascular risk classification in high blood pressure patients]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Arthroplasty register for Germany]
2014     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Arthroscopy of the knee joint for gonarthrosis]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Arthroscopy with joint washout in the treatment of knee arthrosis]
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Artificial disc replacement]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Artificial liver support systems]
2016     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asfotase alfa: assessment according to §35a (para. 1, sentence 10) Social Code Book V]
2013     National Evidence-based Healthcare Collaborating Agency (NECA) [Asian study on the value for a QALY: Korean results]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Aspirin prescription pattern among diabetic patients for prevention of cardiovascular disease]
2014     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment and analysis of studies on rare diseases - rapid report]
2015     Haute Autorite de sante (HAS) [Assessment of an edge-to-edge mitral valve repair clip and its implantation]
1999     Finnish Office for Health Care Technology Assessment (Finohta) [Assessment of an electronic referral and teleconsultation system between secondary and primary health care]
2012     Haute Autorite de sante (HAS) [Assessment of an epiretinal prosthesis and its implantation procedure]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Assessment of bilateral cochlear implants in children. Indication criteria for cochlear implants in children and adults]
2009     Haute Autorite de sante (HAS) [Assessment of breast implants, tissue expanders and external breast prostheses]
2015     Haute Autorite de sante (HAS) [Assessment of diagnostic and therapeutic parotid and submandibular sialendoscopy]
2009     Haute Autorite de sante (HAS) [Assessment of drug-eluting stents]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical cancer]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of effectiveness and safety of Cyberknife and Gamma knife radiosurgery in intra and extracraneal lesions' treatment (update)]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of factors related to the pharmaceutical expenditure in Primary Care, and prescription quality in chronic diseases]
2011     Haute Autorite de sante (HAS) [Assessment of glomerular filtration rate and serum creatinine levels in the diagnosis of chronic kidney disease in adults]
2010     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of healthcare status and therapeutic recommendations concerning attention deficit hyperactivity disorder]
2010     Haute Autorite de sante (HAS) [Assessment of medical devices for home infusion]
2014     Haute Autorite de sante (HAS) [Assessment of non-invasive methods for measuring liver fibrosis in chronic hepatitis B. Initial assessment and follow-up of non-treated adult patients]
2014     Haute Autorite de sante (HAS) [Assessment of real-time optical endomicroscopy performed during mapping of Barrett's esophagus (BE) (for diagnosis of BE-associated early neoplasia)]
2014     Haute Autorite de sante (HAS) [Assessment of spinal cord stimulation]
2002     Finnish Office for Health Care Technology Assessment (Finohta) [Assessment of telemedicine in the Northern Ostrobothnia hospital district]
2013     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of the benefit of screening in persons aged under 55 years with a risk of familial bowel cancer]
2011     National Evidence-based Healthcare Collaborating Agency (NECA) [Assessment of the effectiveness of sublingual immunotherapy and subcutaneous immunotherapy in allergic rhinitis and asthma]
2006     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of the effectiveness of the intraoperative detection of the sentry ganglion in solid tumours]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of the LEADER study on liraglutide - rapid report]
2015     Haute Autorite de sante (HAS) [Assessment of the measurement of cytomegalovirus viral load by gene amplification in allograft recipients]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Assessment of the PARLER (Programme d'Accès Rapide Lavallois en Rhumatologie) program]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of the quality of the registration of administrative variables of the minimum basic data set of short-term hospitals of Osakidetza-Basque Health Service in 2005]
2006     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of the re-designed diagnosis process for colorectal cancer]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of the re-designed diagnosis process for colorectal cancer]
2014     Haute Autorite de sante (HAS) [Assessment of the risks associated with aesthetic mesotherapy practices]
2015     Haute Autorite de sante (HAS) [Assessment of the safety and conditions for conducting autologous fat grafting in reconstructive, restorative and cosmetic breast surgery]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Assessment on nucleic acid amplification techniques (NAT) for human immunodeficiency, hepatitis C and hepatitis B virus screening in blood banks]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Assessment process of research projects submitted to the 2009 calling of the Fundacio La Marato de TV3. Rare diseases]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Assessment process of the research projects submitted to the 2010 call for topics of la Fundació La Marató de TV3. Acquired spinal cord and brain injuries]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Assessments tools for risk prediction of cardiovascular diseases]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Assistance at normal childbirth. Guide for pregnant women, future parents, as well as their partners and relatives]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Assisted reproduction]
2016     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ataluren - assessment according to §35a (para. 1, sentence 10) Social Code Book V]
2015     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ataluren - assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Atazanavir/cobicistat (Evotaz®) in HIV infection]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (non-small cell lung cancer) – benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma, first-line treatment) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma) - benefit assessment according to §35a Social Code Book V]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Atezolizumab in non-small cell lung cancer]
2017     Basque Office for Health Technology Assessment (OSTEBA) [ATOMs – Adjustable Transobturator Male System. Device for urinary incontinence]
2008     Committee for New Health Technology Assessment (CNHTA) [ATP7A gene, mutation analysis]
2008     Committee for New Health Technology Assessment (CNHTA) [ATP7A gene, mutation[sequencing]]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [AUDIT ONCOrisk: Quality of the information in the study about digestive oncological surgery results]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Auditive implants: concept, indications and appropriate use]
2009     Committee for New Health Technology Assessment (CNHTA) [Auditory cortex stimulation]
2009     The Regional Health Technology Assessment Centre (HTA-centrum) [Auricular acupuncture for narcotic dependency]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Autism spectrum disorder: scientific knowledge about the detection, diagnosis and treatment]
2009     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Autism treatment with orthomolecular therapy]
2010     Committee for New Health Technology Assessment (CNHTA) [Autofluorescence image(endoscopy)]
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Autologous blood donations]
2009     Committee for New Health Technology Assessment (CNHTA) [Autologous blood injection]
2008     Committee for New Health Technology Assessment (CNHTA) [Autologous bone marrow cell infusion for advanced liver cirrhosis]
2008     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Autologous chondrocyte implantion. An updated systematic review and tutelage use extension]
2015     Norwegian Institute of Public Health (NIPH) [Autologous hematopoietic stemcell transplantation (HSCT) for multiple sclerosis]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Autologous lymph node transfer for lymphedema secondary to breast cancer]
2009     Committee for New Health Technology Assessment (CNHTA) [Autologous noncultured epidermal cellular transplantation]
2011     Committee for New Health Technology Assessment (CNHTA) [autologous platelet rich plasma application]
2010     Committee for New Health Technology Assessment (CNHTA) [Autologous platelet rich plasma application]
2009     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Autologous stem cell transplantation for breast cancer]
2021     Norwegian Institute of Public Health (NIPH) [Autologous stem cell transplantation for multiple sclerosis : rapid scoping review]
2009     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Autologous stem cell transplantation for soft tissue sarcoma]
2013     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Automated reading methods of uterine cervical cytology]
2008     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Avastin in ophthalmology]
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Avastin® for age-related macular degeneration]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Avelumab (metastatic Merkel cell carcinoma) - benefit assessment according to §35a (1), sentence 11, Social Code Book V]